| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | HCA HOLDINGS INC | 140,000 | 10,588,000 | 3.22% | Put | |
| 2 | STRYKER CORP | 84,333 | 9,817,000 | 2.98% | ||
| 3 | ALLERGAN PLC | 42,500 | 9,788,000 | 2.97% | Put | |
| 4 | FIRST TR EXCHANGE TRADED FD | 150,000 | 9,128,000 | 2.77% | Put | |
| 5 | NXSTAGE MED INC COM | 365,000 | 9,121,000 | 2.77% | ||
| 6 | STRYKER CORP | 75,000 | 8,731,000 | 2.65% | Call | |
| 7 | ABBOTT LABS | 205,000 | 8,669,000 | 2.63% | ||
| 8 | ALEXION PHARMACEUTIC | 66,375 | 8,134,000 | 2.47% | ||
| 9 | AETNA INC NEW | 69,333 | 8,004,000 | 2.43% | ||
| 10 | BARD C R INC | 35,000 | 7,850,000 | 2.38% | Put | |
| 11 | BAXTER INTL INC | 160,000 | 7,616,000 | 2.31% | ||
| 12 | LILLY ELI & CO | 93,375 | 7,494,000 | 2.28% | ||
| 13 | NOVARTIS A G | 92,125 | 7,274,000 | 2.21% | ||
| 14 | AMGEN INC | 43,460 | 7,250,000 | 2.20% | ||
| 15 | SHIRE PLC | 37,391 | 7,249,000 | 2.20% | ||
| 16 | CENTENE CORP DEL | 106,479 | 7,130,000 | 2.17% | ||
| 17 | ATHENA HEALTH INC. | 55,000 | 6,937,000 | 2.11% | ||
| 18 | ENVISION HEALTHCARE HLDGS INC | 307,046 | 6,838,000 | 2.08% | ||
| 19 | ENVISION HEALTHCARE HLDGS INC | 300,000 | 6,681,000 | 2.03% | Put | |
| 20 | K2M GROUP HLDGS INC COM | 375,223 | 6,671,000 | 2.03% | ||
| 21 | LILLY ELI & CO | 81,500 | 6,541,000 | 1.99% | Call | |
| 22 | GLAXOSMITHKLINE PLC | 150,357 | 6,485,000 | 1.97% | ||
| 23 | ZIMMER BIOMET HLDGS INC | 40,652 | 5,286,000 | 1.61% | ||
| 24 | SIENTRA INC | 552,664 | 4,968,000 | 1.51% | ||
| 25 | BOSTON SCIENTIFIC CORP | 200,000 | 4,760,000 | 1.45% | ||
| 26 | MEDPACE HLDGS INC COM | 158,428 | 4,731,000 | 1.44% | ||
| 27 | AVEXIS INC COM | 111,000 | 4,574,000 | 1.39% | ||
| 28 | TENET HEALTHCARE CORP | 200,000 | 4,532,000 | 1.38% | Put | |
| 29 | Intersect ENT Inc | 275,000 | 4,356,000 | 1.32% | ||
| 30 | ALNYLAM PHARMACEUTICALS INC | 61,625 | 4,177,000 | 1.27% | ||
| 31 | JAZZ PHARMACEUTICALS PLC SHS USD | 33,936 | 4,123,000 | 1.25% | ||
| 32 | MOLINA HEALTHCARE INC | 70,000 | 4,082,000 | 1.24% | ||
| 33 | ACADIA PHARMACEUTICALS INC COM | 123,066 | 3,915,000 | 1.19% | ||
| 34 | ALERE INC | 90,000 | 3,892,000 | 1.18% | ||
| 35 | Wright Medical Group NV | 155,000 | 3,802,000 | 1.15% | ||
| 36 | PENUMBRA INC COM | 50,000 | 3,800,000 | 1.15% | ||
| 37 | ABBOTT LABS | 87,700 | 3,709,000 | 1.13% | Call | |
| 38 | GW PHARMACEUTICALS PLC | 27,855 | 3,697,000 | 1.12% | ||
| 39 | AKORN INC | 135,125 | 3,684,000 | 1.12% | ||
| 40 | ZELTIQ AESTHETICS INCORPORATED | 90,000 | 3,530,000 | 1.07% | ||
| 41 | INVACARE CORP COM | 310,000 | 3,463,000 | 1.05% | ||
| 42 | TENET HEALTHCARE CORP | 150,000 | 3,399,000 | 1.03% | Call | |
| 43 | PUMA BIOTECHNOLOGY | 49,125 | 3,294,000 | 1.00% | ||
| 44 | ACCURAY INCORPORATED COM | 500,000 | 3,185,000 | 0.97% | ||
| 45 | HILL ROM HLDGS INC | 50,000 | 3,099,000 | 0.94% | ||
| 46 | Cynosure Inc | 60,000 | 3,056,000 | 0.93% | ||
| 47 | INSULET CORPORATION | 74,600 | 3,054,000 | 0.93% | ||
| 48 | ORTHOFIX INTERNATIONAL NV | 70,000 | 2,994,000 | 0.91% | ||
| 49 | ULTRAGENYX PHARMACEUTICAL INC COM | 39,750 | 2,820,000 | 0.86% | ||
| 50 | KITE PHARMA INCORPORATED | 49,500 | 2,765,000 | 0.84% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001493152-16-014840, filed 2016.11.14).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
